tradingkey.logo
tradingkey.logo

Koninklijke Philips NV

PHG
27.325USD
+0.595+2.23%
Market hours ETQuotes delayed by 15 min
25.99BMarket Cap
25.68P/E TTM

Koninklijke Philips NV

27.325
+0.595+2.23%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Koninklijke Philips NV

Currency: USD Updated: 2026-03-25

Key Insights

Koninklijke Philips NV's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 49 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 32.65.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Koninklijke Philips NV's Score

Industry at a Glance

Industry Ranking
49 / 209
Overall Ranking
141 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Koninklijke Philips NV Highlights

StrengthsRisks
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 25.78, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 50.66M shares, decreasing 19.83% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 25.60K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.19.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
32.650
Target Price
+21.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-25

The current financial score of Koninklijke Philips NV is 8.97, ranking 9 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.93B, representing a year-over-year increase of 10.32%, while its net profit experienced a year-over-year increase of 228.70%.

Score

Industry at a Glance

Previous score
8.97
Change
0

Financials

7.12

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

10.00

Operational Efficiency

8.91

Growth Potential

9.28

Shareholder Returns

9.56

Koninklijke Philips NV's Company Valuation

Currency: USD Updated: 2026-03-25

The current valuation score of Koninklijke Philips NV is 6.01, ranking 175 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 25.78, which is 531.03% below the recent high of 162.70 and 431.48% above the recent low of -85.47.

Score

Industry at a Glance

Previous score
6.01
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 49/209
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-25

The current earnings forecast score of Koninklijke Philips NV is 8.00, ranking 63 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 29.65, with a high of 30.30 and a low of 29.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
32.650
Target Price
+21.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

92
Total
4
Median
7
Average
Company name
Ratings
Analysts
Koninklijke Philips NV
PHG
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-25

The current price momentum score of Koninklijke Philips NV is 7.00, ranking 64 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 31.04 and the support level at 24.95, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.78
Change
0.22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.420
Sell
RSI(14)
40.586
Neutral
STOCH(KDJ)(9,3,3)
36.590
Buy
ATR(14)
0.748
Low Volatility
CCI(14)
-41.906
Neutral
Williams %R
61.732
Sell
TRIX(12,20)
-0.527
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
26.818
Buy
MA10
27.406
Sell
MA20
28.817
Sell
MA50
29.610
Sell
MA100
28.635
Sell
MA200
27.527
Sell

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of Koninklijke Philips NV is 3.00, ranking 135 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 5.33%, representing a quarter-over-quarter decrease of 0.78%. The largest institutional shareholder is Sarah Ketterer, holding a total of 2.20M shares, representing 0.23% of shares outstanding, with 39.55% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Mondrian Investment Partners Ltd.
7.91M
+11.18%
Fiduciary Management, Inc.
7.18M
-3.81%
Dimensional Fund Advisors, L.P.
4.44M
-1.26%
Fidelity Management & Research Company LLC
2.60M
+7.08%
Causeway Capital Management LLC
Star Investors
1.96M
+5.79%
Parametric Portfolio Associates LLC
1.83M
+6.35%
Northern Trust Global Investments
1.64M
+7.99%
Brandes Investment Partners, L.P.
Star Investors
1.62M
+5.73%
Aperio Group, LLC
1.29M
+1.08%
Envestnet Asset Management, Inc.
1.30M
-3.78%
1
2

Risk Assessment

Currency: USD Updated: 2026-03-25

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Koninklijke Philips NV is 8.70, ranking 19 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
8.70
Change
0
Beta vs S&P 500 index
0.81
VaR
+3.36%
240-Day Maximum Drawdown
+20.24%
240-Day Volatility
+29.78%

Return

Best Daily Return
60 days
+11.11%
120 days
+11.11%
5 years
+26.77%
Worst Daily Return
60 days
-4.11%
120 days
-5.50%
5 years
-15.95%
Sharpe Ratio
60 days
+0.37
120 days
+0.20
5 years
+0.08

Risk Assessment

Maximum Drawdown
240 days
+20.24%
3 years
+33.81%
5 years
+78.35%
Return-to-Drawdown Ratio
240 days
+0.76
3 years
+0.34
5 years
-0.12
Skewness
240 days
+1.12
3 years
+3.55
5 years
+1.78

Volatility

Realised Volatility
240 days
+29.78%
5 years
+38.11%
Standardised True Range
240 days
+2.02%
5 years
+2.08%
Downside Risk-Adjusted Return
120 days
+31.11%
240 days
+31.11%
Maximum Daily Upside Volatility
60 days
+35.13%
Maximum Daily Downside Volatility
60 days
+32.46%

Liquidity

Average Turnover Rate
60 days
+0.11%
120 days
+0.11%
5 years
--
Turnover Deviation
20 days
-19.34%
60 days
+7.96%
120 days
+10.52%

Peer Comparison

Healthcare Equipment & Supplies
Koninklijke Philips NV
Koninklijke Philips NV
PHG
7.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
WST
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI